Cargando…
Targeted capture-based NGS is superior to multiplex PCR-based NGS for hereditary BRCA1 and BRCA2 gene analysis in FFPE tumor samples
BACKGROUND: With the introduction of Olaparib treatment for BRCA-deficient recurrent ovarian cancer, testing for somatic and/or germline mutations in BRCA1/2 genes in tumor tissues became essential for treatment decisions. In most cases only formalin-fixed paraffin-embedded (FFPE) samples, containin...
Autores principales: | Zakrzewski, Falk, Gieldon, Laura, Rump, Andreas, Seifert, Michael, Grützmann, Konrad, Krüger, Alexander, Loos, Sina, Zeugner, Silke, Hackmann, Karl, Porrmann, Joseph, Wagner, Johannes, Kast, Karin, Wimberger, Pauline, Baretton, Gustavo, Schröck, Evelin, Aust, Daniela, Klink, Barbara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6487025/ https://www.ncbi.nlm.nih.gov/pubmed/31029168 http://dx.doi.org/10.1186/s12885-019-5584-6 |
Ejemplares similares
-
Germline truncating-mutations in BRCA1 and MSH6 in a patient with early onset endometrial cancer
por: Kast, Karin, et al.
Publicado: (2012) -
BRCA1/2 NGS Somatic Testing in Clinical Practice: A Short Report
por: Pepe, Francesco, et al.
Publicado: (2021) -
Sequencing of BRCA1/2-alterations using NGS-based technology: annotation as a challenge
por: Ebner, Silvana, et al.
Publicado: (2022) -
Validation of AmpliSeq NGS Panel for BRCA1 and BRCA2 Variant Detection in Canine Formalin-Fixed Paraffin-Embedded Mammary Tumors
por: Di Giacomo, Daniela, et al.
Publicado: (2022) -
Addendum: Sequencing of BRCA1/2-alterations using NGS-based technology: annotation as a challenge
por: Ebner, Silvana, et al.
Publicado: (2023)